Search Results

Biotech Beach

DCN Dx and Mapp Biopharmaceutical Announce Subcontract

DCN Dx announced a subcontract with Mapp Biopharmaceutical, Inc., a developer of novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.

February 1, 2023

·

3 min read

Bio NC

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment.

January 23, 2023

·

3 min read

Drug Development

MAPS PBC Announces Publication of Results from Confirmatory Phase 3 “MAPP2" Trial of MDMA-Assisted Therapy for PTSD in Nature Medicine

MAPS Public Benefit Corporation (“MAPS PBC”) announced that data from the company’s MAPP2 clinical trial, a multi-site Phase 3 study of MDMA-assisted therapy for post–traumatic stress disorder (“PTSD”), was published in the September issue of Nature Medicine.

September 14, 2023

·

11 min read

Business

Aridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan-Ebola and Pan-Marburg Monoclonal Antibody Programs from Mapp Biopharmaceutical

Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, signed an exclusive term sheet to secure international development and global commercial rights upon licensure for the pan-Ebola and pan-Marburg monoclonal antibody (mAbs) programs from Mapp Biopharmaceutical, Inc.

December 5, 2022

·

9 min read

Press Releases

Angitia Biopharmaceuticals Announces $120 Million Series C Financing

December 11, 2024

·

4 min read